Loading organizations...
Loading organizations...
Key people at Sinopharm Capital.
Key people at Sinopharm Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 30, 2018 | GenFleet Therapeutics | $17.5M Series A | Ally Bridge Group | CSPC Pharma, Hidragon Capital, TF Capital |
| May 14, 2018 | Ansun BioPharma | $85.0M Series A | Lilly Asia Ventures, Sinopharm Capital | 3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, Oceanpine Capital, VI Ventures, YuanMing Capital |
| Nov 30, 2017 | Semma Therapeutics | $114.0M Series B | Kevin Raidy, Daniel Auerbach | 6 Dimensions Capital, ARCH Venture Partners, F-Prime Capital, JDRF T1D Fund, Medtronic, MPM Capital, Novartis, ORI Healthcare Fund, Wu Capital |
| Feb 8, 2017 | Abbisko Therapeutics | $28.0M Series A | — | Jianxin Capital, Lilly Asia Ventures, TF Capital |
| Aug 5, 2016 | Ambrx | $45.0M Other Equity | Apricot Capital, Northeast Securities | China Everbright, Fosun Pharma, HOPU Investments |
